Drugs / Glucose-Dependent Insulin-Releasing Hormone[3-30]
last change Feb 2020 re-read 3 minutes ago

Glucose-Dependent Insulin-Releasing Hormone[3-30]

also known as GIP\[3-30\]
Developed for
type 1 diabetes mellitus

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT03556098 Comparator Feb 2019 → Feb 2020 type 1 diabetes mellitus Steno Diabetes Center Copenhagen Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Glucose-Dependent Insulin-Releasing Hormone[3-30] ClinicalTrials.gov intervention name — accepted as the source's own label NCT03556098 ↗
Known as GIP\[3-30\] “Infusion of GIP antagonist GIP\[3-30\]” NCT03556098 ↗
Action Inhibit “Infusion of GIP antagonist GIP\[3-30\]” NCT03556098 ↗